baber/WOPTO huggingface dataset:
Patent DE-69613958-T2 (DE)
Inventor: MOLINA GIUSEPPE
IPC: A43D111/00
Filed: 1996-05-03
Granted: 2002-04-04
Abstract: A machine for a shoemaking operation, especially for fixing the upper to the insole, in which suitable mechanical members (12-16) position on a support (11) a shoemaker's last (A) to which is attached the insole (B) and over which is laid the upper (C), grip and stretch the upper (C), clamp the last (A) on the support (11), and fold the upper (C) onto the insole (B) in order to fix the upper to the insole, is also provided with transferring and conveying members (17-21) underneath the support (11), into which the last (A) is discharged under gravity after having been released, and by which the last (A) is passed on for the succeeding operations. This enables the operator to perform the task without the risk of accidents, at high speed, and without damaging the footwear. <IMAGE>
Patent DE-69617030-T2 (DE)
Inventor: GUSTAFSSON STIG
IPC: A23G3/12
Filed: 1996-08-20
Granted: 2002-03-21
Abstract: PCT No. PCT/SE96/01027 Sec. 371 Date May 11, 1998 Sec. 102(e) Date May 11, 1998 PCT Filed Aug. 20, 1996 PCT Pub. No. WO97/10162 PCT Pub. Date Mar. 20, 1997Method for marking an object where the object is placed in a package whereby a pattern in said package is caused to make a marking in said object. Objects being marked with the above method. The invention is especially useful for marking solid or semi-solid formulations of drugs, candy and food-stuff. Specifically the invention is useful to mark nicotine-containing chewing gums. Other solid or semi-solid objects can equally well be marked using the present invention.
Patent DE-69628025-T2 (DE)
Inventor: KADDURAH-DAOUK RIMA
IPC: G06G7/48
Filed: 1996-10-11
Granted: 2004-04-01
Abstract: The present invention relates to the use of creatine compounds including cyclocreatine and creatine phosphate for treating or preventing a metabolic disorder consisting of hyperglycemia, insulin dependent diabetes mellitus, impaired glucose tolerance, hyperinsulinemia, insulin insensitivity, diabetes related diseases in a patient experiencing said disorder. The creatine compounds which can be used in the present method include (1) analogues of creatine which can act as substrates or substrate analogues for the enzyme creatine kinase; (2) compounds which can act as activators or inhibitors of creatine kinase; (3) compounds which can modulate the creatine transporter (4) N-phosphocreatine analogues bearing transferable or non-transferable moieties which mimic the N-phosphoryl group. (5) compounds which modify the association of creatine kinase with other cellular components.
Patent DE-69633405-T2 (DE)
Inventor: GARNICK B
IPC: A61K38/09
Filed: 1996-11-25
Granted: 2005-11-17
Abstract: Methods for treating sex hormone-dependent conditions are disclosed. The methods of the invention generally feature administration to a subject of an LHRH antagonist, in combination with a second therapy. In one embodiment, this second therapy is the performance of a procedure that removes or destroys tumor tissue, such as radical excision, cryosurgery or radiation therapy (external or interstitial). In another embodiment, the second therapy is treatment with an LHRH agonist, either simultaneously with or subsequent to LHRH antagonist therapy. The methods of the invention can further involve administering an antiandrogen and/or an inhibitor of sex steroid biosynthesis to the subject in combination with the LHRH antagonist. Methods for inhibiting the LHRH antagonist - induced hormone surge, whatever its clinical setting, are also disclosed. These methods generally involve administration of an LHRH antagonist in combination with the LHRH agonist. Complete suppression of the LHRH agonist-induced hormone surge has been achieved by pretreatment with a sustained-released formulation of LHRH antagonist.
Patent DE-69637050-T2 (DE)
Inventor: MARGOLIN SOLOMON B
IPC: A61K31/4433
Filed: 1996-09-17
Granted: 2008-06-19
Abstract: In a preferred embodiment, a method for the inhibition of the synthesis and release of tumor necrosis factor from various cells, comprising: administering to a human or other mammal an effective dose of one or more pharmaceutical substances selected from the group consisting of N-substituted 2(1H) pyridones, N-substituted 3(1H) pyridones, and pharmaceutically acceptable salts thereof.
Patent DE-69710761-T2 (DE)
Inventor: OSBORNE MICHAEL ROBERT
IPC: B23K11/087
Filed: 1997-07-11
Granted: 2002-07-18
Abstract: The welding of laminates and lacquered metals is described for the purpose of producing tubular can bodies for three piece cans. The method describes how a coating-free margin is produced on can blanks in order to be able to produce satisfactory welds. A pulsed laser having a short pulse duration of less than 10 mu s and a peak power output of at least 0.1 megawatt is used to clean margins from can blanks of polymer/tinplate laminates which were then welded. A weld latitude of at least 200A was possible for forming can bodies with fully acceptable welds from laminates of tinplate and clear or white polypropylene or white PET, for example.
Patent DE-69719359-T2 (DE)
Inventor: JONES R
IPC: A61K38/00
Filed: 1997-10-21
Granted: 2003-12-04
Abstract: Cyclic peptide compounds having 11 amino acids joined by a linking unit L, such that the linear dimension between the Calpha carbon of the first amino acid and the Calpha carbon of eleventh amino acid is between about 4 and 12 Ångstrom units; are useful for inhibiting the binding of uPA to the uPAR receptor. Methods for using the cyclic peptide compounds, and compositions containing them, for inhibiting the growth or metastasis of cancerous tumors are also disclosed.
Patent DE-69720771-T2 (DE)
Inventor: DUGGAN E
IPC: A61P43/00
Filed: 1997-10-27
Granted: 2004-01-29
Abstract: This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as vitronectin receptor antagonists. The vitronectin receptor antagonist compounds of the present invention are  alpha v beta 3 antagonists,  alpha v beta 5 antagonists or dual  alpha v beta 3/ alpha v beta 5 antagonists useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation and tumor growth.
Patent DE-69720780-T2 (DE)
Inventor: LE LOARER JEAN-LUC
IPC: B01J21/02
Filed: 1997-10-24
Granted: 2004-02-12
Abstract: PCT No. PCT/FR97/01909 Sec. 371 Date Jul. 27, 1999 Sec. 102(e) Date Jul. 27, 1999 PCT Filed Oct. 24, 1997 PCT Pub. No. WO98/18715 PCT Pub. Date May 7, 1998The invention concerns a method for regenerating a working solution for producing hydrogen peroxide 30%, in which the working solution is contacted with alumina at a temperature of approximately 40-160 DEG  C.
Patent DE-69723298-T2 (DE)
Inventor: HIKIDA MUNEO
IPC: C07D487/22
Filed: 1997-09-30
Granted: 2004-02-05
Abstract: The present invention provides an iminochlorin aspartic acid derivative represented by the following formula (I): <CHEM>   Wherein Asp represents an aspartic acid residue, or a pharmaceutically acceptable salt thereof. The compound of the present invention is useful as a photosensitizer for photophysico-chemical diagnosis and therapy of cancer, because it has a high accumulability to cancerous cells, reactivity to external energy and a cancerous cell destroying effect which is effective even againt cancers developing in deep site, while it is rapidly excreted from normal cells and therefore causes no damage thereto.
Patent DE-69723618-T2 (DE)
Inventor: DODGE BERNARD E
IPC: A47K10/42
Filed: 1997-06-04
Granted: 2004-06-09
Abstract: A process for dispensing paper towels comprises loading a stack of interfolded paper towels (20) into a housing (12, 12', 112) provided with a slot (50, 150, 250). Each paper towel (20) in the stack has at least one fold line (34) and a pair of ends (44, 46) extending generally perpendicular to the fold line (34). The stack (20) is loaded so that the paper towels (20) are substantially flat, and so that one of the ends (44, 46) of each paper towel is generally parallel to the length of the slot (50, 150, 250) and faces towards the slot. Individual paper towels (20) are dispensed from the stack (20) through the slot (50, 150, 250). <IMAGE>
Patent DE-69724098-T2 (DE)
Inventor: OKU TERUO
IPC: A61P1/16
Filed: 1997-01-31
Granted: 2004-06-17
Abstract: PCT No. PCT/JP97/00233 Sec. 371 Date Aug. 3, 1998 Sec. 102(e) Date Aug. 3, 1998 PCT Filed Jan. 31, 1997 PCT Pub. No. WO97/28153 PCT Pub. Date Aug. 7, 1997This invention relates to a compound of formula (1) wherein R1 is halogen, etc., R2 is halogen, etc., R3 is amino substituted with substituent(s) selected from the group consisting of lower alkyl and acyl, etc., R4 is heterocyclic (lower)alkyl, R5 is lower alkyl, and A1 is lower alkylene, and pharmaceutically acceptable salts thereof, to processes for preparation thereof, to a pharmaceutical composition comprising the same, and to methods of using the same therapeutically in the prevention and/or the treatment of hypertension or the like.
Patent DE-69725452-T2 (DE)
Inventor: COFFIN STUART
IPC: A61K48/00
Filed: 1997-07-25
Granted: 2004-08-19
Abstract: The present invention provides a herpes simplex virus strain which lacks a functional ICP34.5 gene and a functional ICP27 gene. It also provides the use of a herpes simplex virus strain which lacks a functional ICP34.5 gene and a functional ICP27 gene in the treatment of disorders of, or injuries to, the nervous system of a mammal.
Patent DE-69725881-T2 (DE)
Inventor: TEKAMP-OLSON PATRICIA
IPC: A61K38/18
Filed: 1997-12-12
Granted: 2004-09-09
Abstract: Methods for improving purification and quantification of platelet-derived growth factor (PDGF) proteins having structural heterogeneity are provided. Preparation of substantially pure isoforms of these proteins is achieved using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography. A reverse charged capillary zone electrophoresis method enables quantification of substantially pure isoforms of these proteins resulting from endoproteolytic post-translational modifications. Compositions of the invention are substantially purified isoforms of secreted PDGF proteins having structural heterogeneity, more particularly purified intact, single-clipped, and double-clipped isoforms of recombinant PDGF-BB. Pharmaceutical compositions comprising at least one of these substantially purified recombinant PDGF isoforms and methods for their use in promoting wound healing are also provided.
Patent DE-69822671-T2 (DE)
Inventor: MOTAMED MARGARET
IPC: B65H39/042
Filed: 1998-11-25
Granted: 2005-02-10
Abstract: A hybrid mixed format document that contains document portions prepared by different format sources, such as both black and white and colored pages, prepared by separately printing the colored pages on a color printer, and the black and white pages on a black and white printer. The two document portions are then put in separate locations within a mixed format finishing device. One of the document portions, for example the black and white document portion, includes a cover sheet that provides encoded information, which tells the finishing device how to merge the two document portions into a complete publication. One advantage of the mixed format finishing device is that those pages that contain only text may be printed on a faster, and less costly black and white printer. In a preferred embodiment, the cover sheet controls the document merging process in such a manner that if one document is misprinted or mismerged, the mismerged document may be shuttled aside and merging may continue with the next complete document set.
Patent DE-69826124-T2 (DE)
Inventor: BUREAU MICHEL
IPC: C12N5/08
Filed: 1998-06-30
Granted: 2005-09-15
Abstract: The invention provides a method of transferring in vivo a molecule into a striated muscle cell. More specifically, a method of the invention comprises contacting in vivo a striated muscle cell with a molecule, and electrically stimulating the muscle cell with one or more unipolar pulses of an electric field intensity ranging from 1 to 800 V/cm<SUP>2</SUP>. In one embodiment, the molecule is a nucleic acid encoding a protein of interest. For example, the invention provides methods of promoting angiogenesis and hemostasis.
Patent DE-69828400-T2 (DE)
Inventor: HENNINGSEN JIMMY CIESLA
IPC: H01R9/053
Filed: 1998-10-13
Granted: 2005-12-01
Abstract: Cable connector for coaxial cable, comprising a bushing (2) for providing an axial displacement of parts (4, 5, 6, 7, 8) in the connector, whereby these parts are brought into mechanical and/or electrical engagement with the coaxial cable. The axial displacement is provided by screwing a thread (10) provided on the bushing (2) onto a corresponding thread (9) provided in the main body (1) of the connector. The axial displaceable parts in the connector comprising a ferrule (4) for engaging the outer conductor or screen of the coaxial cable, said ferrule (4) comprising a locking arrangement for preventing rotation of the ferrule and cable. The ferrule (4) comprises a conical surface (11) and the main body (1) of the connector comprises a corresponding conical surface (12), said surfaces (11,12) being brought into locking engagement when axially displaced by the bushing (2), whereby the ferrule (4) and cable are prevented from rotating in the connector. By this construction an improved locking arrangement is provided. By further inserting a friction reducing disc (7) between the bushing (2) and the inner bushing (6) the forces acting on the locking arrangement are reduced. <IMAGE>
Patent DE-69828902-T2 (DE)
Inventor: GAMBETTA A
IPC: C12N15/54
Filed: 1998-11-16
Granted: 2006-01-12
Abstract: The present invention relates to isolated polypeptides having 5-aminolevulinic acid synthase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
Patent DE-69831318-T2 (DE)
Inventor: DIVONE ANTHONY
IPC: C08L83/04
Filed: 1998-03-19
Granted: 2006-05-11
Abstract: A process is provided for preparing a silicone elastomer composition for cosmetic products which includes the steps of feeding the silicone elastomer composition comprising a silicone rubber in a carrier fluid into a reactor, mixing the composition in the reactor, delivering the composition from the reactor into a high pressure pump, pumping the fluid into a device for reducing particles of rubber into smaller sizes and recirculating the resultant size reduced particles back to the reactor. The device for reducing particle size is preferably a high pressure fed homogenizer, most advantageously a sonolator.
Patent DE-69907613-T2 (DE)
Inventor: TSUKAHARA MICHINARI
IPC: B41J2/175
Filed: 1999-12-22
Granted: 2005-05-25
Abstract: A method for recycling an ink cartridge used for a recording apparatus comprises the steps of: discharging residual ink from an ink cartridge wherein a porous member (4) is retained for the absorption of ink; using a cleansing fluid to clean the porous member; discharging the cleansing fluid from the porous member; and impregnating the porous member with ink. <IMAGE>
Patent DE-69909826-T2 (DE)
Inventor: FRANZEN BJOERN
IPC: B65D25/42
Filed: 1999-11-05
Granted: 2004-05-27
Abstract: A container has a chamber (10) for liquid, a pouring opening (30) in the upper part of the chamber and having an essentially vertical longitudinal axis, and a handle (20) arranged above the chamber. In the handle there is an air duct (22), which at a first end emerges in the chamber and at a second end emerges in the pouring opening. In the pouring opening, a wall (34) is placed between a part (36) for liquid which is connected to the chamber and a part (38) for air in which the second end of the air duct emerges. An opening (40) is arranged in the wall between the part for liquid and the part for air. This opening ensures better manufacturing quality and ventilation when the container is emptied.
Patent DE-69915755-T2 (DE)
Inventor: SHIMADA RYOUICHI
IPC: B41J2/01
Filed: 1999-09-22
Granted: 2005-01-13
Abstract: A method and device designed to detect any defects in ink-jet nozzles such as blinding, satellite of ink, ink drop mislocation and uneven printing, wherein a test pattern 15 is printed on a test recording medium 3 with a printing head 4 and the said test pattern is scanned by sensor means 1 to capture an image of a column of ink drops 16 in the test pattern as a group 18, the image being processed to determine the average area of the ink drops, their X direction edge positions or Y direction center-to-center distances for comparison with specified criteria to judge any failure in the ink jetting on a group basis. <IMAGE>
Patent DE-69916201-T2 (DE)
Inventor: MONNIER JEAN-LUC
IPC: G07C9/00
Filed: 1999-09-24
Granted: 2005-04-21
Abstract: The command unit comprises a power supply (10) a timer (12) that forms a time base, a counter (20) and an electronic circuit (14). A keypad (16) is provided for entering commands on sight. The electronic circuit further comprises a microprocessor (26) and various memory types (28,30,32). A connection (34) for a portable computer (36) is provided so that audits, system upgrades and other such tasks can be performed. An Independent claim is included for a procedure of conducting an audit of the locking system.
Patent DE-69922476-T2 (DE)
Inventor: GRIFFITH DAVID ANDREW
IPC: A61P17/02
Filed: 1999-11-12
Granted: 2005-12-15
Abstract: This invention is directed to compounds of the Formula <CHEM> and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenous growth hormone. The compounds of this invention are therapeutically effective in treating osteoporosis and/or frailty, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, attenuating protein catabolic response after a major operation, reducing cachexia and protein loss due to chronic illness, accelerating wound healing, or accelerating the recovery of burn patients or patients having undergone major surgery; improving muscle strength, mobility, maintenance of skin thickness, metabolic homeostasis or renal homeostasis. The compounds of the present invention are also useful in treating osteoporosis and/or frailty when used in combination with: a bisphosphonate compound such as alendronate; estrogen, premarin, and optionally progesterone; an estrogen agonist or antagonist; or calcitonin, and pharmaceutical compositions useful therefor. Further, the present invention is directed to pharmaceutical compositions therapeutically effective for increasing the endogenous production or release of growth hormone in a human or other animal which comprises an effective amount of a compound of the present invention and a growth hormone secretagogue selected from GHRP-6, Hexarelin, GHRP-1, growth hormone releasing factor (GRF), IGF-1, IGF-2 or B-HT920. The invention is also directed to intermediates useful in the preparation of compounds of Formula I.
Patent DE-69930630-T2 (DE)
Inventor: RIBAUDO K
IPC: A61K38/00
Filed: 1999-06-03
Granted: 2007-01-18
Abstract: beta 2-microglobulin fusion proteins and modified forms of  beta 2-microglobulin are disclosed. The fusion proteins are shown to incorporate onto the surface of MHC I expressing mammalian cells and to cause an increased cytotoxic T-cell response to antigens presented by such cells. The fusion proteins are useful in methods of tumor therapy. Modified forms of human  beta 2-microglobulin, particularly a form having a serine to valine transition at amino acid position 55 of the mature protein are shown to have an enhanced affinity for MHC I heavy chain, and are useful both in the disclosed fusion proteins and as a vaccine adjuvant where enhanced cytotoxic T-cell response is desired.
Patent DE-69933789-T2 (DE)
Inventor: QUINN G
IPC: A61M25/00
Filed: 1999-12-02
Granted: 2007-09-13
Abstract: A retention bolster for a flexible tube segment in a corporeal access tube assembly. The bolster includes a body molded in one piece of silicone rubber and cut into two legs along a portion of its length. One of the legs has a collar formed on its free end, with a lip under which the free end of the other leg nestles. To hold the legs together and grip a tube segment between them, an O-ring is rolled over the collar into a depression encircling both legs without contracting into the cut between the legs.
Patent HU-E032410-T2 (HU)
Title: A window lining assembly having an improved mounting fitting
Inventor: NIELSEN THOMAS NOER
IPC: E06B1/34
Filed: 2013-07-15
Abstract: The window lining assembly is composed by a window lining (2) and a lining frame (3). Several mounting fittings (9) connect the lining frame (3) to the window lining (2), each mounting fitting including a first leg (941) for connection to a lining frame piece, and a second leg (942) for connection to a lining panel of the window lining. The first leg (941) of each mounting fitting (9) has a length extending between a first end (913) and a second end (914) exceeding the distance between protruding flanges (315, 314) of the lining frame piece (31), and a width extending between a first side (941 a) and a second side (941 b) not exceeding the distance between the protruding flanges (315, 314).
Patent TR-200000102-T2 (TR)
Title: Otomobil dış dikiz aynasının arka açısını kontrol için cihaz
Inventor: LEE YONG HO
IPC: B60R1/068
Filed: 1998-07-08
Abstract: Otomobil dis dikiz aynasinin arka açisini kontrol için cihazda, ultrason dalgalari belli bir süre; bir ucu ayna yuvasina göre plakaya takilmis olan iç kablonun diger ucunun takilacagi tespit yivlerinin karsisinda kavrama yivleri ile belli uzunlukta olan mesnet çubugu olan kontrolör; iç çemberi üzerinde, kavrama yivlerine tekabül eden, sokulan kontrolörün tespiti için kavrama çikintilari olan kavrama bölümü, mesnet çubugunun kavrama bölümü içine sokuldugu belli uzunluktaki  mesnet deligi, ve kontrolörün kavrama yivlerinin kontrol dügmesinin, kavrama çikintilariyla  ve kontrolörün mesnet çubuguyla kontrol dügmesinin mesnet deliginin birbirleriyle kenetlenecegi sekilde kavrama bölümünün disina  kontrol mahfazasinin sokuldugu yerde belli genislikte kilavuz deligi olan yarim küre seklinde bir flansi  bulunan kontrol dügmesi üzerine uygulanir. Böylece parça sayisi azalir, montaj prosesi basitlesir, imalat maliyeti düser ve kontrol dügmesinin isletme verimi artar.
Patent TR-200003352-T2 (TR)
Title: Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler
Inventor: KOENIG GERD
IPC: A61K31/216
Filed: 1998-06-11
Abstract: Bulus, özellikle kalp ve dolasim sistemi hastaliklarinin tedavisinde eczacilikla ilgili etken maddeler olarak kullanilabilecek, patent istemlerinde tarif edildikleri sekilde pentaeritrit'ten türetilmis yeni bilesimleri tarif etmektedir.
Patent TR-200101105-T2 (TR)
Title: Traş makinesi bıçak sistemi
Inventor: SWANSON GERALD TED
IPC: B26B21/22
Filed: 1999-04-20
Abstract: Bir emniyetli tras makinesi sistemi, yuvayi bir sapa birlestiren bir elemana mil etrafinda dönebilir sekilde baglanmis bir ince uzun yuvayi kapsamaktadir. Yuva, kavisli uç bölümlerine sahip, esas olarak dikdörtgendir. Birden çok tras makinesi biçagi ve bir koruma elemani yuvanin üst yüzeyinden uzanmaktadir ve bir anular yerinde tutma klipi, biçaklarin yuva üzerinde yerinde tutulmasi ve biçaklarin koruma elemanina göre konumlandirilmasina hizmet ederek yuvanin çevre kenari etrafinda tanzim edilmistir. Birlestirme elemani yuvayi, yuvanin birlestirme elemanina göre dönmesi esnasinda yuva üzerinde birbirine uyan yüzeylere temas eden dört es-eksenli dayanma yüzeyi tarafindan yuvayi mil etrafinda dönebilir sekilde desteklemektedir.